LCK and B-cell chronic lymphocytic leukemia: Moreover, studies on chronic lymphocytic leukemia (CLL) showed that LCK expression significantly correlated with the sensitivity of CLL cells to pharmacological treatment and may act as a potential therapeutic target for CLL patients [31,32].